KURA compared with MOLN: revenue, margins and what each company keeps, and the suppliers and customers both name

KURAKura Oncology, Inc.

Mkt capRevenueRevenue

MOLNMolecular Partners AG

Mkt capRevenueRevenue

Compare

KURAKura Oncology, Inc.

MOLNMolecular Partners AG

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

KURA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±10.2%▲+1.51%×0.15

May 13 '26±40.6%▼−2.07%×0.05

Q1 FY26±11.2%▼−0.47%×0.04

Jan 12 '26±6.4%▼−2.55%×0.39

MOLN1 of 4 reports

Reportimpliedrealized× implied

Oct 29 '26—▼−4.88%—

= impliedKURA realized, solidMOLN realized, hatchedOne scale, both sides: full bar = 41%× = |realized| ÷ impliedSource: market data

KURAKura Oncology, Inc.

9.79▼−4.58%· post 9.79

Mkt cap$912.7MRevenue$21MQ2 FY26Revenue$67MFY25

MOLNMolecular Partners AG

3.98▲+11.17%· post 3.40

ClosedNov 2 '26

Mkt cap$144.5MRevenue—Revenue—

Compare

ClosedNov 2 '26

KURAKura Oncology, Inc.

MOLNMolecular Partners AG

9.79▼−4.58%post 9.79

Price

3.98▲+11.17%post 3.40

$912.7M

Mkt cap

$144.5M

Q2 FY26$21M

Revenue

—

FY25$67M

Revenue

—

KURA9.79▼−4.58%vsMOLN3.98▲+11.17%ClosedNov 2 '26